Sara Lucchesi

Prospective Validation of Candidate SNPs of VEGF/VEGFR Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Plus Bevacizumab

Fotios Loupakis, Chiara Cremolini, Dongyun Yang et al. · PLoS ONE · 2013 · 75 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers

Giacomo Allegrini, Teresa Di Desidero, M. Barletta et al. · Angiogenesis · 2012 · 72 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer

Francesca Mazzoni, Fabiana Letizia Cecere, Giulia Meoni et al. · Lung Cancer · 2013 · 38 citations

Medicine, Oncology, Pharmacology +13

Genetic interaction of<i>P2X7</i>receptor and<i>VEGFR-2</i>polymorphisms identifies a favorable prognostic profile in prostate cancer patients

Anna Solini, Vittorio Simeon, Lisa Derosa et al. · Oncotarget · 2015 · 30 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients

Teresa Di Desidero, Lisa Derosa, Luca Galli et al. · Investigational New Drugs · 2016 · 29 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13